Type of prostate cancer-Adenocarcinoma Posts on Medivizor
Navigation Menu

Type of prostate cancer-Adenocarcinoma Posts on Medivizor

Looking for patients with advanced prostate cancer to test a new drug

Posted by on Jul 21, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 1 trial will investigate the safety of an experimental drug, XmAb22841 (XmAb), to treat advanced cancer. The main outcome will be the safety and tolerability of XmAb. This study is recruiting in Georgia and Texas, USA. The details Advanced cancer can be difficult to treat. New drugs are being developed to address this. Immune...

Read More

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer

Posted by on Jul 21, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate ultra-hypofractionated radiation therapy (UHFRT). This study found that UHFRT is safe and effective in the treatment of prostate cancer.  Some background One option for the treatment of prostate cancer is radiation therapy. Conventional radiation treatment (CRT) involves using small doses of radiation 5...

Read More

Outcomes and side-effects after prostate surgery and intensity modulated radiation therapy

Posted by on Jul 21, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate long-term outcomes of radiation therapy after prostate surgery for prostate cancer. This study found that this is a safe treatment option for these patients. Some background Prostate surgery is a common treatment for prostate cancer (PCa). Intensity-modulated radiation therapy (IMRT) is another option....

Read More

Searching for patients with castration-resistant prostate cancer to test this new treatment option

Posted by on May 28, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial is examining the effectiveness and safety of sacituzumab govitecan (IMMU-132) in patients with metastatic castration-resistant prostate cancer (mCRPC) who are having cancer progression on abiraterone (Zytiga) or enzalutamide (Xtandi). The main outcome to be measured will be the PSA (a...

Read More

Looking for patients with localized prostate cancer to test stereotactic body radiotherapy after surgery

Posted by on May 19, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety and effectiveness of stereotactic body radiation therapy (SBRT)  in patients with localized prostate cancer (PC) who had surgical removal of the prostate. The main outcomes will be survival without recurrence and side effects. This study is recruiting in Los Angeles, California, the...

Read More

Is leuprolide mesylate safe and effective in the treatment of advanced prostate cancer?



Posted by on Apr 24, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined the safety and effectiveness of slow-release leuprolide mesylate (LM) administered by injection under the skin (leuprolide mesylate subcutaneous injectable suspension or LMIS), in the treatment of advanced prostate cancer. This study concluded that this medication is safe and effective in the treatment of advanced...

Read More

Searching for men relapsed prostate cancer to test a treatment combination

Posted by on Apr 22, 2019 in Prostate cancer | 0 comments

In a nutshell This trial is looking at blocking androgens (male sex hormones) with different medications in men with raised PSA (a blood marker of prostate cancer) levels after prostate surgery. The main outcome to be measured will be the length of time the patients survive without the cancer progressing. This study is being conducted in the United...

Read More

Looking for men with very high risk prostate cancer to try a combination treatment

Posted by on Apr 22, 2019 in Prostate cancer | 0 comments

In a nutshell This trial is examining how effective different treatments are at shrinking the prostate cancer before surgery. The main outcomes to be measured will be a complete response (complete disappearance of cancer) and minimal residual disease (almost undetectable cancer). This study is being conducted in Massachusetts and New York, the United...

Read More

Looking for men with high-risk prostate cancer features after prostate surgery to trial a type of radiation therapy

Posted by on Apr 17, 2019 in Prostate cancer | 0 comments

In a nutshell This trial is examining the effectiveness of radiation therapy, in treating patients with high-risk prostate cancer features after radical prostatectomy (surgery to remove the prostate gland). The main outcome to be measured will be freedom from failure. Failure is evidence that the cancer has returned. Patients will be followed up for 5...

Read More

Is single fraction high dose brachytherapy for prostate cancer safe and effective? 



Posted by on Mar 24, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined if single fraction, high dose brachytherapy for low and medium risk prostate cancer is safe and effective. This study concluded that this treatment for prostate cancer is safe and effective, however, it should not be used outside of clinical trials.  Some background Prostate cancer can be treated using...

Read More